WHO ICTRP trial
A Study of KRN23 in Pediatric Patients with X-linked Hypophosphatemic…
JPRN-jRCT2080223558 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-jRCT2080223558 |
|---|---|
| Public title | A Study of KRN23 in Pediatric Patients with X-linked Hypophosphatemic Rickets/Osteomalacia |
| Scientific title | A Phase 3 Open-Label Trial to Assess the Efficacy and Safety of KRN23 in Pediatric Patients with X-linked Hypophosphatemic Rickets/Osteomalacia and a Postmarketing Study of KRN23 Switched from the Phase 3 Trial |
| Primary sponsor | Kyowa Kirin Co., Ltd. |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | 3 |
| Countries | Japan |
| Conditions | X-linked Hypophosphatemic Rickets/Osteomalacia |
| Interventions | investigational material(s) Generic name etc : KRN23 INN of investigational material : burosumab Therapeutic category code : 399 Agents affecting metabolism, n.e.c. Dosage and Administration for Investigational material : repeated SC… |
| Registration date | Jun 15, 2017 |
| Target size | 10 |
| Secondary IDs | NCT03233126;JapicCTI-173614 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: